These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 29066190

  • 21. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells.
    Yingkun N, Lvsong Z, Huimin Y.
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1138-46. PubMed ID: 21164560
    [Abstract] [Full Text] [Related]

  • 22. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY, Su JC, Ni MH, Tseng LM, Chu PY, Wang DS, Tai WT, Kao YP, Hung MH, Shiau CW, Chen KF.
    Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
    [Abstract] [Full Text] [Related]

  • 23. Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors.
    Pallandre JR, Borg C, Rognan D, Boibessot T, Luzet V, Yesylevskyy S, Ramseyer C, Pudlo M.
    Eur J Med Chem; 2015 Oct 20; 103():163-74. PubMed ID: 26352675
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
    Huang G, Zhao HR, Meng QQ, Zhang QJ, Dong JY, Zhu BQ, Li SS.
    Eur J Med Chem; 2018 Jan 01; 143():166-181. PubMed ID: 29174813
    [Abstract] [Full Text] [Related]

  • 25. Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors.
    Guo J, Yu W, Cai G, Zhang W, Li S, Zhu J, Song D, Kong L.
    Eur J Med Chem; 2018 May 10; 151():752-764. PubMed ID: 29674294
    [Abstract] [Full Text] [Related]

  • 26. Design, synthesis and biological evaluation of cinnamic acyl shikonin derivatives.
    Lin HY, Chen W, Shi J, Kong WY, Qi JL, Wang XM, Yang YH.
    Chem Biol Drug Des; 2013 Feb 10; 81(2):275-83. PubMed ID: 23066914
    [Abstract] [Full Text] [Related]

  • 27. Identification of galiellalactone-based novel STAT3-selective inhibitors with cytotoxic activities against triple-negative breast cancer cell lines.
    Kim HS, Kim T, Ko H, Lee J, Kim YS, Suh YG.
    Bioorg Med Chem; 2017 Oct 01; 25(19):5032-5040. PubMed ID: 28705432
    [Abstract] [Full Text] [Related]

  • 28. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z, Bradner J, Greenberg E, Mazitschek R, Foster R, Mahoney J, Seiden MV.
    Mol Pharmacol; 2007 Nov 01; 72(5):1137-45. PubMed ID: 17675586
    [Abstract] [Full Text] [Related]

  • 29. Design and characterization of α-lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors.
    Lin HY, Han HW, Sun WX, Yang YS, Tang CY, Lu GH, Qi JL, Wang XM, Yang YH.
    Eur J Med Chem; 2018 Jan 20; 144():137-150. PubMed ID: 29268130
    [Abstract] [Full Text] [Related]

  • 30. Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones.
    Bhasin D, Etter JP, Chettiar SN, Mok M, Li PK.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6864-7. PubMed ID: 24176397
    [Abstract] [Full Text] [Related]

  • 31. Screening and biological evaluation of a novel STAT3 signaling pathway inhibitor against cancer.
    Huang M, Chen Z, Zhang L, Huang Z, Chen Y, Xu J, Zhang J, Shu X.
    Bioorg Med Chem Lett; 2016 Nov 01; 26(21):5172-5176. PubMed ID: 27727126
    [Abstract] [Full Text] [Related]

  • 32. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
    Dandawate P, Ahmad A, Deshpande J, Swamy KV, Khan EM, Khetmalas M, Padhye S, Sarkar F.
    Bioorg Med Chem Lett; 2014 Jul 01; 24(13):2900-4. PubMed ID: 24835626
    [Abstract] [Full Text] [Related]

  • 33. Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target.
    Timofeeva OA, Gaponenko V, Lockett SJ, Tarasov SG, Jiang S, Michejda CJ, Perantoni AO, Tarasova NI.
    ACS Chem Biol; 2007 Dec 21; 2(12):799-809. PubMed ID: 18154267
    [Abstract] [Full Text] [Related]

  • 34. Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3.
    Wang X, He Q, Wu K, Guo T, Du X, Zhang H, Fang L, Zheng N, Zhang Q, Ye F.
    Eur J Med Chem; 2019 Oct 01; 179():218-232. PubMed ID: 31254923
    [Abstract] [Full Text] [Related]

  • 35. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
    Guo Y, Zhao Y, Wang G, Chen Y, Jiang Y, Ouyang L, Liu B.
    Eur J Med Chem; 2018 Jan 01; 143():402-418. PubMed ID: 29202403
    [Abstract] [Full Text] [Related]

  • 36. Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway.
    Gara RK, Srivastava VK, Duggal S, Bagga JK, Bhatt M, Sanyal S, Mishra DP.
    J Biomed Sci; 2015 Apr 01; 22(1):26. PubMed ID: 25879420
    [Abstract] [Full Text] [Related]

  • 37. Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
    Lee JS, Oh Y, Lee JS, Park JH, Shin JK, Han JH, Kim HS, Yoon S.
    In Vivo; 2022 Apr 01; 36(5):2105-2115. PubMed ID: 36099094
    [Abstract] [Full Text] [Related]

  • 38. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
    Falamarzian A, Aliabadi HM, Molavi O, Seubert JM, Lai R, Uludağ H, Lavasanifar A.
    J Biomed Mater Res A; 2014 Sep 01; 102(9):3216-28. PubMed ID: 24167124
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and Evaluation of New Naphthalene and Naphthoquinone Derivatives as Anticancer Agents.
    Beretta GL, Ribaudo G, Menegazzo I, Supino R, Capranico G, Zunino F, Zagotto G.
    Arch Pharm (Weinheim); 2017 Jan 01; 350(1):. PubMed ID: 27990691
    [Abstract] [Full Text] [Related]

  • 40. Design, synthesis, and studies of small molecule STAT3 inhibitors.
    Bhasin D, Cisek K, Pandharkar T, Regan N, Li C, Pandit B, Lin J, Li PK.
    Bioorg Med Chem Lett; 2008 Jan 01; 18(1):391-5. PubMed ID: 18006313
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.